0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027
Published Date: September 2021
|
Report Code: QYRE-Auto-34O6484
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global and United States Tick borne Encephalitis Inactivated Vaccine Market Insights Forecast to 2027

Global and United States Tick-borne Encephalitis Inactivated Vaccine Market Insights, Forecast to 2027

Code: QYRE-Auto-34O6484
Report
September 2021
133 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Tick-borne Encephalitis Inactivated Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tick-borne Encephalitis Inactivated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Tick-borne Encephalitis Inactivated Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus

Segment by Application

Pediatric Vaccines
Adult Vaccines
Traveler Vaccines

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

Pfizer
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health
1 Study Coverage
1.1 Tick-borne Encephalitis Inactivated Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Type
1.2.2 European TBE Virus
1.2.3 Far Eastern TBE Virus
1.2.4 Siberian TBE Virus
1.3 Market by Application
1.3.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Application
1.3.2 Pediatric Vaccines
1.3.3 Adult Vaccines
1.3.4 Traveler Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Revenue 2016-2027
2.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Sales 2016-2027
2.2 Global Tick-borne Encephalitis Inactivated Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tick-borne Encephalitis Inactivated Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Tick-borne Encephalitis Inactivated Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tick-borne Encephalitis Inactivated Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Region (2022-2027)
3 Global Tick-borne Encephalitis Inactivated Vaccine Competitor Landscape by Players
3.1 Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Sales
3.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Revenue
3.2.1 Key Tick-borne Encephalitis Inactivated Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tick-borne Encephalitis Inactivated Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tick-borne Encephalitis Inactivated Vaccine Revenue in 2020
3.2.6 Global Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tick-borne Encephalitis Inactivated Vaccine Price by Manufacturers
3.4 Global Tick-borne Encephalitis Inactivated Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Tick-borne Encephalitis Inactivated Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tick-borne Encephalitis Inactivated Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Tick-borne Encephalitis Inactivated Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Type (2016-2021)
4.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021)
4.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2021)
4.1.3 Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tick-borne Encephalitis Inactivated Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Application (2016-2021)
5.1.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021)
5.1.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2021)
5.1.3 Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2021)
5.2 Tick-borne Encephalitis Inactivated Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
6.1.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales YoY Growth 2016-2027
6.1.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue YoY Growth 2016-2027
6.1.3 United States Tick-borne Encephalitis Inactivated Vaccine Market Share in Global Market 2016-2027
6.2 United States Tick-borne Encephalitis Inactivated Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Tick-borne Encephalitis Inactivated Vaccine Players by Sales (2016-2021)
6.2.2 United States Top Tick-borne Encephalitis Inactivated Vaccine Players by Revenue (2016-2021)
6.3 United States Tick-borne Encephalitis Inactivated Vaccine Historic Market Review by Type (2016-2021)
6.3.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2021)
6.3.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 United States Tick-borne Encephalitis Inactivated Vaccine Price by Type (2016-2021)
6.4 United States Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027)
6.4.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 United States Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Type (2022-2027)
6.5 United States Tick-borne Encephalitis Inactivated Vaccine Historic Market Review by Application (2016-2021)
6.5.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2021)
6.5.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 United States Tick-borne Encephalitis Inactivated Vaccine Price by Application (2016-2021)
6.6 United States Tick-borne Encephalitis Inactivated Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027)
6.6.2 United States Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 United States Tick-borne Encephalitis Inactivated Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
7.2 North America Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
7.2.1 North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
7.2.2 North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
9.2.1 Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
9.2.2 Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
10.2.1 Latin America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 Encephalitis
12.2.1 Encephalitis Corporation Information
12.2.2 Encephalitis Description and Business Overview
12.2.3 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Encephalitis Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.2.5 Encephalitis Recent Development
12.3 Cochrane Collaboration
12.3.1 Cochrane Collaboration Corporation Information
12.3.2 Cochrane Collaboration Description and Business Overview
12.3.3 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.3.5 Cochrane Collaboration Recent Development
12.4 Sonic HealthPlus
12.4.1 Sonic HealthPlus Corporation Information
12.4.2 Sonic HealthPlus Description and Business Overview
12.4.3 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.4.5 Sonic HealthPlus Recent Development
12.5 Superdrug Health
12.5.1 Superdrug Health Corporation Information
12.5.2 Superdrug Health Description and Business Overview
12.5.3 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.5.5 Superdrug Health Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Tick-borne Encephalitis Inactivated Vaccine Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tick-borne Encephalitis Inactivated Vaccine Industry Trends
13.2 Tick-borne Encephalitis Inactivated Vaccine Market Drivers
13.3 Tick-borne Encephalitis Inactivated Vaccine Market Challenges
13.4 Tick-borne Encephalitis Inactivated Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tick-borne Encephalitis Inactivated Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of European TBE Virus
    Table 3. Major Manufacturers of Far Eastern TBE Virus
    Table 4. Major Manufacturers of Siberian TBE Virus
    Table 5. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 6. Global Tick-borne Encephalitis Inactivated Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 7. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Regions (2016-2021) & (K Units)
    Table 8. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Regions (2016-2021)
    Table 9. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Regions (2016-2021) & (US$ Million)
    Table 10. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Region (2022-2027) & (K Units)
    Table 11. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 12. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 13. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 14. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Manufacturers (2016-2021) (K Units)
    Table 15. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Manufacturers (2016-2021)
    Table 16. Ranking of Global Top Tick-borne Encephalitis Inactivated Vaccine Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Tick-borne Encephalitis Inactivated Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 18. Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 19. Global Tick-borne Encephalitis Inactivated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 20. Global Tick-borne Encephalitis Inactivated Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tick-borne Encephalitis Inactivated Vaccine as of 2020)
    Table 21. Key Manufacturers Tick-borne Encephalitis Inactivated Vaccine Price (2016-2021) (USD/Unit)
    Table 22. Tick-borne Encephalitis Inactivated Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Tick-borne Encephalitis Inactivated Vaccine Product Type
    Table 24. Date of International Manufacturers Enter into Tick-borne Encephalitis Inactivated Vaccine Market
    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 26. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Type (2016-2021) (K Units)
    Table 27. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2016-2021)
    Table 28. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Type (2016-2021) (US$ Million)
    Table 29. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2016-2021)
    Table 30. Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Table 31. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Type (2022-2027) & (K Units)
    Table 32. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 33. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
    Table 34. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 35. Global Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
    Table 36. Global Tick-borne Encephalitis Inactivated Vaccine Sales by Application (2016-2021) (K Units)
    Table 37. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2016-2021)
    Table 38. Global Tick-borne Encephalitis Inactivated Vaccine Revenue by Application (2016-2021) (US$ Million)
    Table 39. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2016-2021)
    Table 40. Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Table 41. Global Tick-borne Encephalitis Inactivated Vaccine Sales Forecast by Application (2022-2027) & (K Units)
    Table 42. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 43. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 44. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 45. Global Tick-borne Encephalitis Inactivated Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
    Table 46. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) of Key Companies (2016-2021)
    Table 47. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Company (2016-2021)
    Table 48. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) by Company (2016-2021)
    Table 49. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Company (2016-2021)
    Table 50. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Type (2016-2021)
    Table 51. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2016-2021)
    Table 52. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 53. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2016-2021)
    Table 54. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Type (2022-2027)
    Table 55. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Type (2022-2027)
    Table 56. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 57. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2022-2027)
    Table 58. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Type (2022-2027)
    Table 59. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Application (2016-2021)
    Table 60. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2016-2021)
    Table 61. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 62. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2016-2021)
    Table 63. United States Tick-borne Encephalitis Inactivated Vaccine Sales (K Units) by Application (2022-2027)
    Table 64. United States Tick-borne Encephalitis Inactivated Vaccine Sales Share by Application (2022-2027)
    Table 65. United States Tick-borne Encephalitis Inactivated Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 66. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2022-2027)
    Table 67. United States Tick-borne Encephalitis Inactivated Vaccine Price (USD/Unit) by Application (2022-2027)
    Table 68. North America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
    Table 69. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
    Table 70. North America Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 71. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
    Table 72. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales by Region (2016-2021) & (K Units)
    Table 73. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2021)
    Table 74. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2021)
    Table 76. Europe Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
    Table 77. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
    Table 78. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 79. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
    Table 80. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
    Table 81. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
    Table 82. Latin Americaa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 83. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
    Table 84. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales by Country (2016-2021) & (K Units)
    Table 85. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country (2016-2021)
    Table 86. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 87. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country (2016-2021)
    Table 88. Pfizer Corporation Information
    Table 89. Pfizer Description and Business Overview
    Table 90. Pfizer Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 91. Pfizer Tick-borne Encephalitis Inactivated Vaccine Product
    Table 92. Pfizer Recent Development
    Table 93. Encephalitis Corporation Information
    Table 94. Encephalitis Description and Business Overview
    Table 95. Encephalitis Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 96. Encephalitis Product
    Table 97. Encephalitis Recent Development
    Table 98. Cochrane Collaboration Corporation Information
    Table 99. Cochrane Collaboration Description and Business Overview
    Table 100. Cochrane Collaboration Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 101. Cochrane Collaboration Product
    Table 102. Cochrane Collaboration Recent Development
    Table 103. Sonic HealthPlus Corporation Information
    Table 104. Sonic HealthPlus Description and Business Overview
    Table 105. Sonic HealthPlus Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 106. Sonic HealthPlus Product
    Table 107. Sonic HealthPlus Recent Development
    Table 108. Superdrug Health Corporation Information
    Table 109. Superdrug Health Description and Business Overview
    Table 110. Superdrug Health Tick-borne Encephalitis Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 111. Superdrug Health Product
    Table 112. Superdrug Health Recent Development
    Table 113. Tick-borne Encephalitis Inactivated Vaccine Market Trends
    Table 114. Tick-borne Encephalitis Inactivated Vaccine Market Drivers
    Table 115. Tick-borne Encephalitis Inactivated Vaccine Market Challenges
    Table 116. Tick-borne Encephalitis Inactivated Vaccine Market Restraints
    Table 117. Tick-borne Encephalitis Inactivated Vaccine Customers List
    Table 118. Tick-borne Encephalitis Inactivated Vaccine Distributors List
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tick-borne Encephalitis Inactivated Vaccine Product Picture
    Figure 2. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type in 2020 & 2027
    Figure 3. European TBE Virus Product Picture
    Figure 4. Far Eastern TBE Virus Product Picture
    Figure 5. Siberian TBE Virus Product Picture
    Figure 6. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application in 2020 & 2027
    Figure 7. Pediatric Vaccines
    Figure 8. Adult Vaccines
    Figure 9. Traveler Vaccines
    Figure 10. Tick-borne Encephalitis Inactivated Vaccine Report Years Considered
    Figure 11. Global Tick-borne Encephalitis Inactivated Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Tick-borne Encephalitis Inactivated Vaccine Market Size 2016-2027 (US$ Million)
    Figure 13. Global Tick-borne Encephalitis Inactivated Vaccine Sales 2016-2027 (K Units)
    Figure 14. Global Tick-borne Encephalitis Inactivated Vaccine Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region (2016-2021)
    Figure 16. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region in 2020
    Figure 17. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region (2016-2021)
    Figure 18. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region in 2020
    Figure 19. Global Tick-borne Encephalitis Inactivated Vaccine Sales Share by Manufacturer in 2020
    Figure 20. The Top 10 and 5 Players Market Share by Tick-borne Encephalitis Inactivated Vaccine Revenue in 2020
    Figure 21. Tick-borne Encephalitis Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 22. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type (2016-2021)
    Figure 23. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Type in 2020
    Figure 24. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type (2016-2021)
    Figure 25. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Type in 2020
    Figure 26. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application (2016-2021)
    Figure 27. Global Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Application in 2020
    Figure 28. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application (2016-2021)
    Figure 29. Global Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Application in 2020
    Figure 30. United States Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2027 (K Units)
    Figure 31. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. United States Tick-borne Encephalitis Inactivated Vaccine Market Share in Global Market 2016-2027
    Figure 33. United States 5 and 10 Largest Tick-borne Encephalitis Inactivated Vaccine Players Market Share by Revenue in Tick-borne Encephalitis Inactivated Vaccine in 2020
    Figure 34. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Type (2016-2021)
    Figure 35. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate by Type in 2016 & 2020
    Figure 36. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Share by Application (2016-2021)
    Figure 37. United States Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate by Application in 2016 & 2020
    Figure 38. North America Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
    Figure 39. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 40. North America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
    Figure 41. North America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
    Figure 42. U.S. Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 43. U.S. Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Canada Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 45. Canada Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
    Figure 47. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 48. Europe Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
    Figure 49. Europe Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
    Figure 50. Germany Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Germany Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. France Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 53. France Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. U.K. Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 55. U.K. Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Italy Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Italy Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Russia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 59. Russia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
    Figure 61. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 62. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Region in 2020
    Figure 63. Asia Pacific Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Region in 2020
    Figure 64. China Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 65. China Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Japan Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 67. Japan Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. South Korea Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 69. South Korea Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. India Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 71. India Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Australia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Australia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. Taiwan Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 75. Taiwan Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Indonesia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Indonesia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Thailand Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Thailand Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Malaysia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Malaysia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Philippines Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 83. Philippines Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 84. Vietnam Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 85. Vietnam Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 86. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
    Figure 87. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 88. Latin America Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
    Figure 89. Latin America Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
    Figure 90. Mexico Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 91. Mexico Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Brazil Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 93. Brazil Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 94. Argentina Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 95. Argentina Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 96. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate 2016-2021 (K Units)
    Figure 97. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 98. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Sales Market Share by Country in 2020
    Figure 99. Middle East and Africa Tick-borne Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2020
    Figure 100. Turkey Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 101. Turkey Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Saudi Arabia Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 103. Saudi Arabia Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 104. UAE Tick-borne Encephalitis Inactivated Vaccine Sales Growth Rate (2016-2021) (K Units)
    Figure 105. UAE Tick-borne Encephalitis Inactivated Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 106. Tick-borne Encephalitis Inactivated Vaccine Value Chain
    Figure 107. Channels of Distribution
    Figure 108. Distributors Profiles
    Figure 109. Bottom-up and Top-down Approaches for This Report
    Figure 110. Data Triangulation
    Figure 111. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart